REVIEW article

Front. Pharmacol.

Sec. Renal Pharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1627253

This article is part of the Research TopicReviews in Renal Pharmacology: 2024View all 13 articles

Critical role of LncRNA in sepsis-associated acute kidney injury

Provisionally accepted
Lingjian  JinLingjian Jin1Jian  LiaoJian Liao2Jin  LitongJin Litong3Chunyan  ChenChunyan Chen2Feng  YuanFeng Yuan3*
  • 1Linhai Second People's Hospital of Taizhou, Linhai, China
  • 2Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China
  • 3Taizhou Central Hospital, Taizhou, China

The final, formatted version of the article will be published soon.

Sepsis is defined as organ dysfunction resulting from a harmful host response to infection. It can lead to multiple organ dysfunction, with the kidneys being one of the most commonly affected organs, resulting in sepsis-associated acute kidney injury (SA-AKI), which is associated with a high mortality rate. Despite significant advances in the treatment of SA-AKI in recent years, the condition continues to exhibit a high mortality rate. It remains a critical issue and clinical burden that necessitates further research to mitigate both acute and chronic consequences. An in-depth exploration of the pathogenesis of SA-AKI is essential for guiding early diagnosis and treatment. Increasing evidence indicates that long non-coding RNAs (LncRNAs) play a crucial role in SA-AKI, typically functioning as competing endogenous RNAs (ceRNAs) that alleviate the inhibition of downstream target genes by microRNAs (miRNAs), thus regulating downstream signaling pathways and participating in vital cellular biological processes and inflammatory responses. A growing number of studies have reported the involvement of LncRNAs in SA-AKI, highlighting the necessity of summarizing the evidence on this topic through a comprehensive review, as LncRNAs can either promote the onset or inhibit the progression of SA-AKI depending on the underlying mechanisms. This paper reviews the pathophysiological mechanisms contributing to the development of SA-AKI, the pivotal role of LncRNAs in this condition, and their potential as biomarkers and therapeutic targets, aiming to provide theoretical guidance for the study and treatment of SA-AKI.

Keywords: Sepsis, lncRNAs, SA-AKI, Inflammation, signaling pathway

Received: 12 May 2025; Accepted: 11 Jun 2025.

Copyright: © 2025 Jin, Liao, Litong, Chen and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Feng Yuan, Taizhou Central Hospital, Taizhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.